494 related articles for article (PubMed ID: 14529302)
1. Boron neutron capture therapy: cellular targeting of high linear energy transfer radiation.
Coderre JA; Turcotte JC; Riley KJ; Binns PJ; Harling OK; Kiger WS
Technol Cancer Res Treat; 2003 Oct; 2(5):355-75. PubMed ID: 14529302
[TBL] [Abstract][Full Text] [Related]
2. The radiation biology of boron neutron capture therapy.
Coderre JA; Morris GM
Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
Barth RF; Soloway AH; Brugger RM
Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
[TBL] [Abstract][Full Text] [Related]
4. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
6. A Model for Estimating Dose-Rate Effects on Cell-Killing of Human Melanoma after Boron Neutron Capture Therapy.
Matsuya Y; Fukunaga H; Omura M; Date H
Cells; 2020 Apr; 9(5):. PubMed ID: 32365916
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
8. The basis and advances in clinical application of boron neutron capture therapy.
He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
[TBL] [Abstract][Full Text] [Related]
10. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
[TBL] [Abstract][Full Text] [Related]
11. Neutron activation of patients following boron neutron capture therapy of brain tumors at the high flux reactor (HFR) Petten (EORTC Trials 11961 and 11011).
Wittig A; Moss RL; Stecher-Rasmussen F; Appelman K; Rassow J; Roca A; Sauerwein W
Strahlenther Onkol; 2005 Dec; 181(12):774-82. PubMed ID: 16362787
[TBL] [Abstract][Full Text] [Related]
12. A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research.
Perks CA; Mill AJ; Constantine G; Harrison KG; Gibson JA
Br J Radiol; 1988 Dec; 61(732):1115-26. PubMed ID: 3064858
[TBL] [Abstract][Full Text] [Related]
13. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages.
Miyatake S; Kawabata S; Kajimoto Y; Aoki A; Yokoyama K; Yamada M; Kuroiwa T; Tsuji M; Imahori Y; Kirihata M; Sakurai Y; Masunaga S; Nagata K; Maruhashi A; Ono K
J Neurosurg; 2005 Dec; 103(6):1000-9. PubMed ID: 16381186
[TBL] [Abstract][Full Text] [Related]
14. Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour.
Postuma I; Magni C; Marcaccio B; Fatemi S; Vercesi V; Ciocca M; Magro G; Orlandi E; Vischioni B; Ronchi S; Liu YH; Han Y; Geng C; González SJ; Bortolussi S
Sci Rep; 2024 Jan; 14(1):418. PubMed ID: 38172585
[TBL] [Abstract][Full Text] [Related]
15. Boron Neutron Capture Therapy: Clinical Application and Research Progress.
Cheng X; Li F; Liang L
Curr Oncol; 2022 Oct; 29(10):7868-7886. PubMed ID: 36290899
[TBL] [Abstract][Full Text] [Related]
16. Cell survival measurements in an argon, aluminium and sulphur filtered neutron beam: a comparison with 24 keV neutrons and relevance to boron neutron capture therapy.
Mill AJ; Morgan GR; Newman SM
Br J Radiol; 1994 Oct; 67(802):1008-16. PubMed ID: 8000825
[TBL] [Abstract][Full Text] [Related]
17. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy at the crossroads: challenges and opportunities.
Barth RF
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy for malignant gliomas.
Diaz AZ; Coderre JA; Chanana AD; Ma R
Ann Med; 2000 Feb; 32(1):81-5. PubMed ID: 10711581
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT.
Seneviratne DS; Saifi O; Mackeyev Y; Malouff T; Krishnan S
Cells; 2023 May; 12(10):. PubMed ID: 37408232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
